The China dermal fillers market is expected to grow at the highest CAGR of 8.7% during the forecast period. China’s market has both medium and long-term potential due to its large market size, aging population, and sedentary lifestyle. The Chinese economy is becoming an R&D-intensive economy which is the major factor for the growth of the market in China. Some of the major factors propelling the growth of the market include the increasing disposable personal income and influencing average income coupled with the changing consumer habits in the Chinese population. Along with this, the significant presence of the middle-aged population is another of the prominent factors that drive the growth of the market in China.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/china-dermal-fillers-market
The China dermal fillers market can be segmented based on application, type, and end-users. Based on application, the market is classified into face-lift, lip treatment/enhancement, facial line correction treatment, and other application. Moreover, based on type, the market is segmented into collagen fillers, poly-L-lactic acid, hyaluronic acid, calcium hydroxylapatite, and others. Based on end-users, the market is segmented into dermatology clinics and hospitals. Among types, the calcium hydroxylapatite is projected to exhibit a significant growth rate in the market due to technology advancement and new product development.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/china-dermal-fillers-market
There are several companies operating in China dermal fillers market in China include Allergan PLC, Galderma Laboratories, L.P., Merz Pharmaceuticals GmbH, Cynosure LLC, Prollenium Medical Technologies, Inc., and Teoxane SA. Bioha Laboratories produces medical sodium hyaluronate gel, having international standard hardware and facilities and European CE & ISO market products. The company offers its products in more than 30 countries. The company’s branded beauty product, Reyoungel, is an HA dermal filler which is a biodegradable gel made of non-animal cross-linked HA. Reyoungel helps in treating facial lines, wrinkles, and lips to create natural-looking results and is used for facial sculpting and body reshaping.
Market Segmentation
By Application
- Face-Lift
- Lip Treatment/Enhancement
- Facial Line Correction Treatment
- Others (Acne Scar Treatment)
By Type
- Collagen Fillers
- Ploy-L-Lactic Acid (PLLA)
- Hyaluronic Acid (HA)
- Calcium Hydroxylapatite (CaHA)
- Others (Autologous Fat Injections and Polymethylmethacrylate (PMMA))
By End-User
- Dermatology Clinics
- Hospitals
Company Profiles
- Allergan PLC
- BIOHA Laboratories
- BioPlus Co., Ltd.
- Croma-Pharma GmbH
- Cynosure LLC
- Korman Laboratories Ltd.
- Galderma Laboratories, L.P.
- Huons Co. Ltd.
- Merz Pharmaceuticals GmbH
- Sculpt Luxury Dermal Fillers Ltd.
- Shanghai Bioha Technologies Co., Ltd.
- Sinclair Pharma Ltd.
- Teoxane SA
- Vivacy Laboratories
- Zhejiang Jingjia Medical Technology Co., Ltd.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
